Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells. by Samer Kayali (133888)

“…<p>A: NN10#5 cells have been cultured for two days in absence or presence of Dox used to induce Fli-1 knock-down before analysis. …”

Candidate general linear models of the highest-ranked variable from each theme (1. availability of family planning, 2. quality of family planning, 3. education, 4. religion, 5. mor... by Corey J. A. Bradshaw (8032406)

Number of bars of length greater than <i>ℓ</i> = 4000 in the barcodes obtained via the binary model (left) and the fuzzy binary model (right) as a function of <i>τ</i>. by Samir Chowdhury (5715338)

Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

Kaplan–Meier estimate for quintiles (Q1–Q5, highest) of the apoB/apoA-1 ratio (apo-ratio) for major adverse cardiovascular events in men and women. by Göran Walldius (286838)

Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. by Niraj K. Nirala (424266)

“…Comparison of different FOXO in liver tissue of wild type (+/+) and CERT heterozygous (+/−) mice shows significant decrease in their transcript levels. (C). Comparison of glycolytic genes in skeletal muscle from wild type (+/+) and CERT heterozygous (+/−) mice shows greater than 5 fold increase in transcript levels of phosphoglycerate mutase and pyruvate kinase and 1.8 fold increase in hexokinase. …”

Characteristics of households, women and men by survey round, Bangladesh 2004–2018. by Phuong Hong Nguyen (3240171)

Subjects:

Decrease in the Inflammatory Marker TNF-α after Consumption of Flaxseed by Hypercholesterolemic Rabbits by Maynara Leonardi Schuh Martins (5223500)

Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation. by Zhijun Zhang (315079)

Subjects:

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

URBAN FOREST COMPONENTS INFLUENCING MICROCLIMATE AND COOLING POTENTIAL1 by Angeline Martini (4699567)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”

CI decreases laminin degradation and attenuates I/R injury in the dog heart. by Junying Zheng (154714)

“…<p>(a) Compared to the normal LV (left panel), I/R results in a decrease in the laminin staining in this border region (right panel). …”

Transduction of Gsx2 decreases the capacity of GESCs to differentiate into neurons, astrocytes and oligodendrocytes. by Héctor R. Méndez-Gómez (189198)

Inflammation is not sufficient to account for decreased relative bacterial numbers in higher dose infection. by Matthew Calverley (109776)

“…D) CCR2 KO animals exhibited a significant decrease in the number of recruited Ly6c+/CD11b+/CD11c+ monocytes at day 9 PI in high dose infection. …”

A savanna response to precipitation intensity by Ryan S. Berry (3913207)

“…Greater root numbers at 20–40 cm and greater woody plant uptake of a hydrological tracer from 45–60 cm suggested that woody plants increased growth by increasing root number and activity (but not root area) in deeper soils. …”

Decrease of junctional zone area in low protein placentas at E10.5, E17.5 and E18.5. by Paula N. Gonzalez (372538)

Boxplot of children’s rated emotion valence during the baseline phase, and on the first and second test trial of Study 1. by Stella C. Gerdemann (12436680)

Decreased proliferation in <i>AnxA2</i>kd and <i>AnxA5</i>kd cells. by Damian C. Genetos (325684)